drugset / Trial / NCT00003184

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

NCT00003184

Treatment

Summary

RATIONALE: Vaccines made from breast cancer cells may make the body build an immune response to kill tumor cells. PURPOSE: Phase I trial to study the effectiveness of vaccines made from breast cancer cells in treating women with metastatic breast cancer.

Timeline

Start
1996-08
Primary completion
Completion
2003-07

Drugs

EvaluationDrugModalityDoseRoute
Subject BCG vaccine Vaccine Intramuscular
Subject CD80 breast cancer vaccine Unknown Intramuscular
Subject sargramostim Protein / enzyme biologic

Indications